DRRX

Durect Stock Price

1.64
-0.05 (-2.96%)
Upgrade to Real-Time
Regular Market
1.64
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Durect Corp DRRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -2.96% 1.64 15:38:46
Close Price Low Price High Price Open Price Previous Close
1.62 1.72 1.67 1.69
Bid Price Ask Price Spread News
1.64 1.65 0.01 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,281 525,105 $ 1.67 $ 876,672 944,304 0.9502 - 4.10
Last Trade Time Type Quantity Stock Price Currency
15:38:46 100 $ 1.64 USD

Durect Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 330.95M 200.58M 173.87M $ 29.56M $ -1.08M -0.12 -305.86
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - 2.70%

more financials information »

Durect News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical DRRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.771.851.621.77881,422-0.13-7.34%
1 Month2.032.031.521.74943,822-0.39-19.21%
3 Months2.302.861.522.051,090,043-0.66-28.7%
6 Months1.332.961.252.201,275,6410.3123.31%
1 Year2.254.100.95022.201,255,017-0.61-27.11%
3 Years1.724.100.461.70904,819-0.08-4.65%
5 Years2.434.100.461.61761,184-0.79-32.51%

Durect Description

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, Remoxy, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.